Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

FOLD holding history

Amicus Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FOLD overviewAll 13F holders of FOLDFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of FOLD by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−15,957,913−100.0%Sold outHolders
Q1 202615,957,913$230.8M<0.1%+10,064,625+170.8%AddedHolders
Q4 20255,893,288$83.9M<0.1%+4,162,433+240.5%AddedHolders
Q3 20251,730,855$13.6M<0.1%+37,563+2.2%AddedHolders
Q2 20251,693,292$9.70M<0.1%+356,421+26.7%AddedHolders
Q1 20251,336,871$10.9M<0.1%+256,840+23.8%AddedHolders
Q4 20241,080,031$10.2M<0.1%+516,059+91.5%AddedHolders
Q3 2024563,972$6.02M<0.1%+77,205+15.9%AddedHolders
Q2 2024486,767$4.83M<0.1%−411,129−45.8%ReducedHolders
Q1 2024897,896$10.6M<0.1%+73,188+8.9%AddedHolders
Q4 2023824,708$11.7M<0.1%+303,038+58.1%AddedHolders
Q3 2023521,670$6.34M<0.1%+121,102+30.2%AddedHolders
Q2 2023400,568$5.03M<0.1%+130,321+48.2%AddedHolders
Q1 2023270,247$3.00M<0.1%−306,104−53.1%ReducedHolders
Q4 2022576,351$7.04M<0.1%+392,760+213.9%AddedHolders
Q3 2022183,591$1.92M<0.1%−96,739−34.5%ReducedHolders
Q2 2022280,330$3.01M<0.1%−232,112−45.3%ReducedHolders
Q1 2022512,442$4.85M<0.1%+36,572+7.7%AddedHolders
Q4 2021475,870$5.50M<0.1%+148,024+45.2%AddedHolders
Q3 2021327,846$3.13M<0.1%+184,656+129.0%AddedHolders
Q2 2021143,190$1.38M<0.1%−185,310−56.4%ReducedHolders
Q1 2021328,500$3.25M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.